Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Clinical Pharmacology|December 20, 2003
Dropout rates with olanzapine or risperidone: a multi-centre observational studyF Pelagotti, B Santarlasci, F Vacca, et al.
Minerva Anestesiologica|May 1, 1990
[Total intravenous anesthesia with propofol vs. propofol/N2O anesthesia]C D'Angelo, F Vacca, S Perin, et al.
Neuroendocrinology|February 1, 1988
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal womenG B Melis, A Cagnacci, M Gambacciani, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Climacteric modifications in body weight and fat tissue distributionM Gambacciani, M Ciaponi, B Cappagli, et al.
Fertility and Sterility|September 1, 1989
Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administrationG B Melis, M Gambacciani, A M Paoletti, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veraliprideG B Melis, A Cagnacci, M Gambacciani, et al.
Life Sciences|January 1, 1989
Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid systemA Cagnacci, G B Melis, R Soldani, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1987
Dexamethasone reduces the postcastration gonadotropin rise in womenG B Melis, V Mais, M Gambacciani, et al.
Maturitas|August 22, 2001
Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapyM Gambacciani, M Ciaponi, B Cappagli, et al.
Obstetrics and Gynecology|November 1, 1988
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal womenG B Melis, M Gambacciani, A Cagnacci, et al.
Pageof 13